Busulfan

규격

55-98-1CAS 번호

200-250-2EC 번호

4-methylsulfonyloxybutyl methanesulfonateIUPAC 명칭

C6H14O6S2화학식

246.3 g/mol분자량

busulfan; 55-98-1; Myleran; Busulphan; Sulphabutin; Leucosulfan; Busulfex; Myelosan; Myeloleukon; Sulfabutin; Mablin; Mielucin; Misulban; Mitostan; Mylecytan; Mielevcin; Mielosan; Milecitan; Mileran; Myeleukon; 1,4-BUTANEDIOL DIMETHANESULFONATE; 1,4-Dimesyloxybutane; 1,4-Butanediol, dimethanesulfonate; Busulfano; Busulfanum; Myelosanum; 1,4-Dimethanesulfonoxybutane; Tetramethylene dimethane sulfonate; Busilvex; Mitosan; 1,4-Dimethylsulfonyloxybutane; NCI-C01592; 1,4-Bis(methanesulfonoxy)butane; 1,4-Butanediol dimethylsulfonate; NSC-750; 1,4-Bis(methanesulfonyloxy)butane; GT 41; Tetramethylene bis(methanesulfonate); 1,4-Butanediol dimethanesulphonate; CB 2041; Methanesulfonic acid, tetramethylene ester; NSC 750; Tetramethylenester kyseliny methansulfonove; C.B. 2041; DTXSID3020910; Bisulfex; NSC750; 4-(methanesulfonyloxy)butyl methanesulfonate; Tetramethylene bis[methanesulfonate]; G1LN9045DK; 1,4-Bis[methanesulfonoxy]butane; CHEBI:28901; DTXCID10910; BUSULFAN FRESENIUS KABI; 4-04-00-00019 (Beilstein Handbook Reference); CB-2041; Bussulfam; Joacamine; Misulfan; 1,4-di(methanesulfonyloxy)butane; GT-41; RefChem:5626; Tetramethylenedimethanesulfonate; 1,4-di(methylsulfonyloxy)butane; L01AB01; 1, 4-Bis(methanesulfonoxy)butane; methanesulfonic acid tetramethylene ester; 1,4-Bitanediol Dimethanesulfonate Esters; WR-19508; 200-250-2; Glyzophrol; Wellcome, Busulfan; Citosulfan; Buzulfan; butane-1,4-diyl dimethanesulfonate; Busulphane; 1,4-Dimethanesulfonyloxybutane; 4-methylsulfonyloxybutyl methanesulfonate; 1,4-Dimethylsulfonoxybutane; AN 33501; 1,4-Dimethanesulphonyloxybutane; X 149; GT 2041; 1,4-Butanediol, dimethanesulphonate; MFCD00007562; 2041 C. B.; G.T. 41; s1692; NCGC00090905-06; Busulfanum [INN-Latin]; Busulfano [INN-Spanish]; Methanesulfonic; CAS-55-98-1; CCRIS 418; Busulfan; Butane-1,4-diyl di(methanesulfonate); SR-01000765405; EINECS 200-250-2; BRN 1791786; UNII-G1LN9045DK; AI3-25012; Busulfan/Myleran; Busulfex IV; Busulfan [USP:INN:BAN:JAN]; Busulfan CRS; HSDB 7605; Tetramethylenester kyseliny methansulfonove [Czech]; Prestwick_989; Tetramethylene {bis[methanesulfonate]}; 1,4-Butanediol-dimethanesulfonate Esters; Spectrum_000092; BUSULFAN [HSDB]; BUSULFAN [IARC]; BUSULFAN [INN]; BUSULFAN [JAN]; 2041 C.B.; BUSULFAN [MI]; BUSULFAN [VANDF]; Spectrum2_000067; Spectrum3_000320; Spectrum4_000259; Spectrum5_000928; BUSULFAN [MART.]; BUSULFAN [WHO-DD]; BUSULFAN [WHO-IP]; CHEMBL820; NCIMech_000192; SCHEMBL4373; BUSULFAN [EMA EPAR]; MYELOSANUM [WHO-IP]; WLN: WS1&O4OSW1; BSPBio_001920; KBioGR_000698; KBioSS_000512; MLS001076666; Busulfan (Myleran, Busulfex); DivK1c_000847; SPECTRUM1500152; Busulfan (JP18/USP/INN); SPBio_000253; BUSULFAN [EP IMPURITY]; BUSULFAN [ORANGE BOOK]; GTPL7136; orb1224664; orb1310165; orb3141182; BUSULFAN [EP MONOGRAPH]; BUSULFAN [USP MONOGRAPH]; COVZYZSDYWQREU-UHFFFAOYSA-; HMS502K09; KBio1_000847; KBio2_000512; KBio2_003080; KBio2_005648; KBio3_001420; butane-1,4-diyldimethanesulfonate; BUSULFANUM [WHO-IP LATIN]; NINDS_000847; GLXC-07732; HMS1920I07; HMS2091O09; HMS2233H04; HMS3259G15; HMS3370E11; HMS3655A21; HMS3712A20; HMS5079P12; Pharmakon1600-01500152; HY-B0245; MSK10327; Tox21_111038; Tox21_201848; Tox21_300318; 1, {4-Bis[methanesulfonoxy]butane}; 2041CB; AC-198; BDBM50237623; CCG-35458; EBC-03587; NSC755916; AKOS003614975; Tox21_111038_1; DB01008; FB19365; KS-5212; NC00498; NSC-755916; IDI1_000847; NCGC00090905-01; NCGC00090905-02; NCGC00090905-03; NCGC00090905-04; NCGC00090905-05; NCGC00090905-07; NCGC00090905-08; NCGC00090905-09; NCGC00090905-10; NCGC00090905-11; NCGC00090905-12; NCGC00090905-20; NCGC00254038-01; NCGC00259397-01; 4-(methylsulfonyloxy)butyl methylsulfonate; NCI60_041640; SMR000058613; SY029743; TETRAMETHYLENE DI(METHANESULFONATE); SBI-0051300.P003; B1022; B7973; NS00010142; ST45022142; SW198555-3; C06862; D00248; D88731; EN300-118686; 4-[(Methylsulfonyl)oxy]butyl methanesulfonate #; AB00051929-10; AB00051929-11; AB00051929_12; AB00051929_14; Busulfan, analytical standard, for drug analysis; F001734; Q348922; SR-01000765405-2; SR-01000765405-3; SR-01000765405-7; BRD-K23204545-001-15-6; BRD-K23204545-001-16-4; BRD-K23204545-001-18-0; Busulfan Working Standard (Secondary Reference Standard); Busulfan, European Pharmacopoeia (EP) Reference Standard; Z276508890; InChI=1/C6H14O6S2/c1-13(7,8)11-5-3-4-6-12-14(2,9)10/h3-6H2,1-2H3동의어